Notably, in NCI-H460 cells, ophiopogonin B suppressed the PAM signaling pathway than in NCI-H157 cells, suggesting it as a potential inhibitor of the PI3K/AKT pathway for the treatment of NSCLC (Chen et al., 2013). The gene discussed is PIK3CG; the disease is non-small cell lung carcinoma.